Clinical Trials Logo
  1. Home
  2. Behcet's Disease
  3. NCT06276829

Behçet and LDH/Albumin

Behcet's Disease Clinical Trial

Official title:
A Convenient Parameter for Predicting Behçet's Disease Severity: Lactate Dehydrogenase/Albumin Ratio

Clinical Trial Summary

ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls. Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06276829
Study type Observational [Patient Registry]
Source Ataturk University
Contact
Status Completed
Phase
Start date February 1, 2020
Completion date April 1, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05635266 - A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed NCT02190916 - Vasculitis Illness Perception (VIP) Study N/A
Completed NCT04065672 - Low-dose IL-2 Treatment on Behcet's Disease Phase 2
Recruiting NCT02593565 - Vasculitis Pregnancy Registry
Completed NCT00167583 - Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB) Phase 3
Completed NCT03371095 - Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease Phase 3
Completed NCT01960790 - Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Completed NCT03531385 - Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease
Completed NCT02190942 - VCRC Patient Contact Registry Patient-Reported Data Validation Study
Completed NCT04328064 - The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease N/A
Not yet recruiting NCT06285539 - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases Phase 2
Completed NCT02190929 - Educational Needs of Patients With Systemic Vasculitis N/A
Completed NCT02476292 - Impact of Vasculitis on Employment and Income N/A
Completed NCT03543709 - Evaluation of Fibromyalgia With Disease Activity and Clinical Findings in Women With Behçet's Disease
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT01988506 - Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Phase 2
Recruiting NCT01952275 - Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases N/A
Completed NCT01532570 - Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions Phase 3
Completed NCT03410290 - Journey of Patients With Vasculitis From First Symptom to Diagnosis
Completed NCT02176070 - Reproductive Health in Men and Women With Vasculitis N/A